Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 55,595 | 75,798 | 54,996 | 55,048 | 48,855 |
| Operating Income | -55,595 | -75,798 | -54,996 | -55,048 | -48,855 |
| Other Income | 4,985 | 5,743 | 6,495 | 7,518 | 8,295 |
| Pre-tax Income | -50,610 | -70,055 | -48,501 | -47,530 | -40,560 |
| Net Income Continuous | -50,610 | -70,055 | -48,501 | -47,647 | -40,560 |
| Net Income | $-50,610 | $-70,055 | $-48,501 | $-47,647 | $-40,560 |
| EPS Basic Total Ops | -0.77 | -1.07 | -0.74 | -0.72 | -0.63 |
| EPS Basic Continuous Ops | -0.86 | -1.19 | -0.82 | -0.79 | -0.70 |
| EPS Diluted Total Ops | -0.77 | -1.07 | -0.74 | -0.72 | -0.63 |
| EPS Diluted Continuous Ops | -0.86 | -1.19 | -0.82 | -0.79 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.77 | -1.07 | -0.74 | -0.73 | -0.69 |
| EBITDA(a) | $-55,516 | $-75,721 | $-54,920 | $-54,971 | $-48,779 |